Subtype
Malignant Neoplasm of Lung - Multiple Primary Sites
CI-CAN-00001149MPLCExplore in graph →
2 active trials
- NCIt
- C139565
Loading cancer entity…
Subtype
CI-CAN-00001149MPLCExplore in graph →
Clinical trials
9 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (0)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06699979 | Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes | recruiting | — | 300 | Central South UniversityOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT05053802 | Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial(MAGIC) | recruiting | Phase 2 | 146 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 |
| Sep 23, 2021 |
| clinicaltrials |
Data updated 22 days agoSource updated Jul 7, 2026source: clinicaltrials